Beacon Pharmaceuticals PLC Financial and Operational Details

Beacon Pharmaceuticals PLC is a leading pharmaceutical company with a strong presence in the market. The company's financial performance is a key indicator of its operational efficiency.

Beacon Pharmaceuticals PLC reported a revenue of £100 million in 2020, a 15% increase from the previous year. This growth can be attributed to the company's successful product launches and strategic partnerships.

The company's operational efficiency is reflected in its ability to maintain a low debt-to-equity ratio of 0.5, indicating a strong financial position.

For another approach, see: Financial Efficiency Ratios

Beacon Pharmaceuticals is a company with a presence in multiple regions. It has a stock listed on the market under the ticker symbol BEACONPHAR.

The income statement and estimates for Beacon Pharmaceuticals can be tailored to specific country editions, including NORTH AMERICA and APAC.

You can find Beacon Pharmaceuticals' financial information by selecting your edition.

The company's annual revenue was $44.3 million in 2025.

Beacon Pharmaceuticals has a strong leadership team in place, with Mohammed Ebadul Karim serving as both the CEO and Chairman of the company.

Mohammed Ebadul Karim has been with the company since 2001 and has been its CEO since then. He is 68 years old and has been the Chairman since 2011.

The company's Director of Finance/CFO is Mohammed Jalal Uddin, but unfortunately, his age and start date are not listed. Anisur Rahman Khan is the Chief Administrative Officer, but his age and start date are also not available.

Here is a brief overview of the company's leadership team:

Managers and Directors play a crucial role in the success of any organization.

Mohammed Ebadul Karim has been the CEO of Beacon Pharmaceuticals PLC since 2001. He is also the Chairman of the company, a position he has held since 2011. As the CEO, he has been leading the company for nearly two decades.

The company has a diverse team of Directors, each with their own unique role.

Here's a breakdown of the Directors:

Mohammed Jalal Uddin is the Director of Finance/CFO at Beacon Pharmaceuticals PLC, but his age and date of appointment are not specified.

Anisur Khan is the Vice President of Beacon Pharmaceuticals Ltd. His role is a key part of the company's management team.

The Vice President of a company plays a crucial role in making strategic decisions and overseeing various aspects of the business.

Expand your knowledge: Review of the Role and Effectiveness of Non-executive Directors

Beacon Pharmaceuticals is a well-established company with a strong presence in the pharmaceutical industry. They have a diverse portfolio of products that cater to various medical needs.

The company's operations are spread across multiple locations, with a large manufacturing facility in Mumbai, India. This facility is equipped with state-of-the-art technology and follows strict quality control measures.

Beacon Pharmaceuticals has a dedicated team of professionals who work tirelessly to ensure the smooth functioning of their operations. They have a strong focus on research and development, which enables them to innovate and improve their products continuously.

The company's commitment to quality is reflected in their adherence to international standards, including those set by the US FDA and the European Medicines Agency. This ensures that their products meet the highest standards of quality and safety.

Beacon Pharmaceuticals has a robust supply chain management system in place, which enables them to deliver their products to customers in a timely and efficient manner. This is critical in the pharmaceutical industry, where timely delivery is essential for maintaining patient safety and satisfaction.

Related reading: Strong Dollar Policy